{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:27:03Z","timestamp":1793320023475,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T00:00:00Z","timestamp":1737849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.psychres.2025.116378","type":"journal-article","created":{"date-parts":[[2025,1,26]],"date-time":"2025-01-26T01:34:50Z","timestamp":1737855290000},"page":"116378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Distribution and correlates of long-acting injectable antipsychotic use among community mental health center patients"],"prefix":"10.1016","volume":"345","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2273-2160","authenticated-orcid":false,"given":"Matthew C.","family":"Lohman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8382-283X","authenticated-orcid":false,"given":"Victoria","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-4252-3645","authenticated-orcid":false,"given":"Mansi","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5698-5744","authenticated-orcid":false,"given":"Eve","family":"Fields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2025.116378_bib0001","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4088\/JCP.11m07161","article-title":"Race and long-acting antipsychotic prescription at a community mental health center: a retrospective chart review","volume":"73","author":"Aggarwal","year":"2012","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116378_bib0002","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1186\/s12888-023-05095-y","article-title":"Examining racial disparity in psychotic disorders related ambulatory care visits: an observational study using national ambulatory medical care survey 2010\u20132015","volume":"23","author":"Bazargan-Hejazi","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2025.116378_bib0003","doi-asserted-by":"crossref","first-page":"63","DOI":"10.36469\/jheor.2021.22979","article-title":"Long-acting injectable antipsychotic use in patients with schizophrenia and criminal justice system encounters","volume":"8","author":"Bhatta","year":"2021","journal-title":"J. Health Econ. Outcomes Res."},{"key":"10.1016\/j.psychres.2025.116378_bib0004","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1007\/s12325-017-0507-x","article-title":"Long-acting injectable antipsychotics in Schizophrenia: literature review and practical perspective, with a focus on aripiprazole once-monthly","volume":"34","author":"Biagi","year":"2017","journal-title":"Adv. Ther."},{"key":"10.1016\/j.psychres.2025.116378_bib0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/2045125314540297","article-title":"The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal","volume":"4","author":"Brissos","year":"2014","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116378_bib0006","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1176\/appi.ps.201300001","article-title":"State and demographic variation in use of depot antipsychotics by Medicaid beneficiaries with schizophrenia","volume":"65","author":"Brown","year":"2014","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.psychres.2025.116378_bib0007","doi-asserted-by":"crossref","first-page":"183","DOI":"10.9740\/mhc.2023.08.183","article-title":"Racial and ethnic differences in patterns of use and discontinuation of long-acting injectable antipsychotics using Medicaid claims data","volume":"13","author":"Caballero","year":"2023","journal-title":"Ment. Health Clin."},{"key":"10.1016\/j.psychres.2025.116378_bib0008","first-page":"549","article-title":"Adherence, health care utilization, and costs between long-acting injectable and oral antipsychotic medications in South Carolina Medicaid beneficiaries with schizophrenia","volume":"30","author":"Cai","year":"2024","journal-title":"J. Manag. Care Spec. Pharm."},{"key":"10.1016\/j.psychres.2025.116378_bib0009","doi-asserted-by":"crossref","first-page":"229","DOI":"10.9740\/mhc.2024.06.229","article-title":"Rural ambulatory care pharmacists providing in-clinic and home visit services improve adherence to long-acting injectable antipsychotics","volume":"14","author":"Chang","year":"2024","journal-title":"Ment. Health Clin."},{"key":"10.1016\/j.psychres.2025.116378_bib0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-244X-12-20","article-title":"A patient perspective of the impact of medication side effects on adherence: results of a cross-sectional nationwide survey of patients with schizophrenia","volume":"12","author":"Dibonaventura","year":"2012","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2025.116378_bib0011","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-244X-13-58","article-title":"Attitudes towards the administration of long-acting antipsychotics: a survey of physicians and nurses","volume":"13","author":"Geerts","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2025.116378_bib0012","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.4088\/JCP.14com09541","article-title":"Long-acting injectable antipsychotics: an underutilized treatment option","volume":"75","author":"Heres","year":"2014","journal-title":"J. Clin. Psychiatry"},{"issue":"Suppl 2","key":"10.1016\/j.psychres.2025.116378_bib0013","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/S0924-9338(14)70001-X","article-title":"Treatment of early episode in patients with schizophrenia: the role of long acting antipsychotics","volume":"29","author":"Heres","year":"2014","journal-title":"Eur. Psychiatry J. Assoc. Eur. Psychiatr."},{"key":"10.1016\/j.psychres.2025.116378_bib0014","first-page":"7822","article-title":"Identifying access barriers faced by rural and dispersed communities to better address their needs: implications and lessons learned for rural proofing for health in the Americas and beyond","volume":"23","author":"Houghton","year":"2023","journal-title":"Rural Remote Health"},{"key":"10.1016\/j.psychres.2025.116378_bib0015","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2025.116378_bib0016","doi-asserted-by":"crossref","first-page":"14S","DOI":"10.1177\/088740341305805s03","article-title":"A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: part I-patient perspectives","volume":"58","author":"Iyer","year":"2013","journal-title":"Can. J. Psychiatry Rev. Can. Psychiatr."},{"key":"10.1016\/j.psychres.2025.116378_bib0017","article-title":"A qualitative study of experiences with and perceptions regarding long-acting injectable antipsychotics: part II-physician perspectives","volume":"58","author":"Iyer","year":"2013","journal-title":"Can. J. Psychiatry Rev. Can. Psychiatr."},{"key":"10.1016\/j.psychres.2025.116378_bib0018","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.psychres.2008.11.003","article-title":"Attitudes towards long-acting depot antipsychotics: a survey of patients, relatives and psychiatrists","volume":"175","author":"Jaeger","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2025.116378_bib0019","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1001\/jamapsychiatry.2020.2076","article-title":"Effect of long-acting injectable antipsychotics vs usual care on time to first hospitalization in early-phase schizophrenia: a randomized clinical trial","volume":"77","author":"Kane","year":"2020","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psychres.2025.116378_bib0020","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2147\/PPA.S53795","article-title":"Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia","volume":"7","author":"Kaplan","year":"2013","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.psychres.2025.116378_bib0021","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fphar.2013.00091","article-title":"Determinants of patient adherence: a review of systematic reviews","volume":"4","author":"Kardas","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.psychres.2025.116378_bib0022","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1471-2474-12-78","article-title":"Medical decision-making among Hispanics and non-Hispanic Whites with chronic back and knee pain: a qualitative study","volume":"12","author":"Katz","year":"2011","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.psychres.2025.116378_bib0023","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/2045125312464106","article-title":"Patients\u2019 and clinicians\u2019 attitude towards long-acting depot antipsychotics in subjects with a first episode of psychosis","volume":"3","author":"Kirschner","year":"2013","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.psychres.2025.116378_bib0024","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S2215-0366(21)00039-0","article-title":"Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies","volume":"8","author":"Kishimoto","year":"2021","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2025.116378_bib0025","doi-asserted-by":"crossref","first-page":"957","DOI":"10.4088\/JCP.13r08440","article-title":"Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies","volume":"74","author":"Kishimoto","year":"2013","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116378_bib0026","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/schbul\/sbs150","article-title":"Long-acting injectable vs oral antipsychotics for relapse prevention in schizophrenia: a meta-analysis of randomized trials","volume":"40","author":"Kishimoto","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2025.116378_bib0027","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/bmb\/ldv017","article-title":"Antipsychotic medication in schizophrenia: a review","volume":"114","author":"Lally","year":"2015","journal-title":"Br. Med. Bull."},{"key":"10.1016\/j.psychres.2025.116378_bib0028","doi-asserted-by":"crossref","first-page":"s57","DOI":"10.1192\/bjp.195.52.s57","article-title":"Community treatment orders and antipsychotic long-acting injections","volume":"195","author":"Lambert","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116378_bib0029","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/104012371502700403","article-title":"Racial differences in antipsychotic use: claims database analysis of Medicaid-insured patients with schizophrenia","volume":"27","author":"Lawson","year":"2015","journal-title":"Ann. Clin. Psychiatry Off. J. Am. Acad. Clin. Psychiatr."},{"key":"10.1016\/j.psychres.2025.116378_bib0030","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","article-title":"Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis","volume":"379","author":"Leucht","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2025.116378_bib0031","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1080\/13696998.2023.2189859","article-title":"Antipsychotic utilization, healthcare resource use and costs, and quality of care among fee-for-service Medicare beneficiaries with schizophrenia in the United States","volume":"26","author":"Li","year":"2023","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.psychres.2025.116378_bib0032","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.34016","article-title":"Racial and ethnic disparities in long-acting injectable antipsychotic use in a national sample of medicare beneficiaries with schizophrenia","volume":"6","author":"Li","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.psychres.2025.116378_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0267808","article-title":"Long-acting injectable antipsychotics for early psychosis: a comprehensive systematic review","volume":"17","author":"Lian","year":"2022","journal-title":"PLoS ONE"},{"key":"10.1016\/j.psychres.2025.116378_bib0034","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/eip.13202","article-title":"Efficacy of long-acting injectable versus oral antipsychotic drugs in early psychosis: a systematic review and meta-analysis","volume":"16","author":"Lian","year":"2022","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116378_bib0035","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s40263-021-00815-y","article-title":"Real-world evidence of the clinical and economic impact of long-acting injectable versus oral antipsychotics among patients with schizophrenia in the United States: a systematic review and meta-analysis","volume":"35","author":"Lin","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2025.116378_bib0036","article-title":"Long-acting injectable antipsychotics for schizophrenia: sociodemographic characteristics and treatment adherence","volume":"19","author":"McCreath","year":"2017","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116378_bib0037","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jpsychires.2023.07.005","article-title":"Short communication: prevalence of long-acting injectable antipsychotic use in Canadian early intervention services for psychosis","volume":"165","author":"McKee","year":"2023","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2025.116378_bib0038","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s40501-017-0115-z","article-title":"The use of long-acting injectable antipsychotics in schizophrenia","volume":"4","author":"Miyamoto","year":"2017","journal-title":"Curr. Treat. Options Psychiatry"},{"key":"10.1016\/j.psychres.2025.116378_bib0039","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1525-1497.2004.30143.x","article-title":"Asian Americans\u2019 Reports of their health care experiences","volume":"19","author":"Ngo-Metzger","year":"2004","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.psychres.2025.116378_bib0040","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1080\/13696998.2022.2084234","article-title":"National and regional description of healthcare measures among adult Medicaid beneficiaries with schizophrenia within the United States","volume":"25","author":"Patel","year":"2022","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.psychres.2025.116378_bib0041","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1177\/0269881109103133","article-title":"Are depot antipsychotics more coercive than tablets? The patient's perspective","volume":"24","author":"Patel","year":"2010","journal-title":"J. Psychopharmacol. Oxf. Engl."},{"key":"10.1016\/j.psychres.2025.116378_bib0042","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1192\/bjp.195.52.s1","article-title":"Antipsychotic long-acting injections: mind the gap","volume":"52","author":"Patel","year":"2009","journal-title":"Br. J. Psychiatry. Suppl."},{"key":"10.1016\/j.psychres.2025.116378_bib0043","doi-asserted-by":"crossref","first-page":"17","DOI":"10.64719\/pb.4590","article-title":"Oral antipsychotic versus long-acting injections antipsychotic in Schizophrenia spectrum disorder: a mirror analysis in a real-world clinical setting","volume":"49","author":"Poloni","year":"2019","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.psychres.2025.116378_bib0044","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/1471-244X-13-261","article-title":"Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia","volume":"13","author":"Potkin","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2025.116378_bib0045","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3371\/CSRP.PORI.050614","article-title":"A pilot study of cultural\/racial differences in patient perspectives on long-acting injectable antipsychotics for the treatment of schizophrenia","volume":"10","author":"Potkin","year":"2017","journal-title":"Clin. Schizophr. Relat. Psychoses"},{"key":"10.1016\/j.psychres.2025.116378_bib0046","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(21)01997-8","article-title":"Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis","volume":"399","author":"Schneider-Thoma","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2025.116378_bib0047","first-page":"e1772","article-title":"Ethnic and age disparities in patients taking long-acting injectable Atypical antipsychotics","volume":"9","author":"Soleman","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.psychres.2025.116378_bib0048","unstructured":"StataCorp, 2021. Stata statistical software: release 17."},{"key":"10.1016\/j.psychres.2025.116378_bib0049","doi-asserted-by":"crossref","first-page":"56","DOI":"10.9740\/mhc.2018.03.056","article-title":"Evaluation of adherence and persistence with oral versus long-acting injectable antipsychotics in patients with early psychosis","volume":"8","author":"Titus-Lay","year":"2018","journal-title":"Ment. Health Clin."},{"key":"10.1016\/j.psychres.2025.116378_bib0050","unstructured":"United States Department of Agriculture, Economic Research Service, 2024. Rural-urban commuting area codes. [WWW Document]. URL https:\/\/www.ers.usda.gov\/data-products\/rural-urban-commuting-area-codes\/documentation\/ (accessed 7.20.24)."},{"key":"10.1016\/j.psychres.2025.116378_bib0051","unstructured":"U.S. Census Bureau, 2024. QuickFacts: South Carolina [WWW Document]. URL https:\/\/www.census.gov\/quickfacts\/fact\/table\/SC\/AGE775222 (accessed 12.28.24)."},{"key":"10.1016\/j.psychres.2025.116378_bib0052","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2105\/AJPH.2017.304276","article-title":"Racial\/ethnic variation in the impact of the Affordable Care Act on insurance coverage and access among young adults","volume":"108","author":"VanGarde","year":"2018","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.psychres.2025.116378_bib0053","doi-asserted-by":"crossref","first-page":"s43","DOI":"10.1192\/bjp.195.52.s43","article-title":"Attitudes of patients and mental health staff to antipsychotic long-acting injections: systematic review","volume":"195","author":"Waddell","year":"2009","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116378_bib0054","first-page":"282","article-title":"Involuntary administration of long-acting injectable antipsychotics for competency restoration","volume":"50","author":"Wang","year":"2022","journal-title":"J. Am. Acad. Psychiatry Law"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125000277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125000277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:39:54Z","timestamp":1777336794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178125000277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":54,"alternative-id":["S0165178125000277"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116378","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distribution and correlates of long-acting injectable antipsychotic use among community mental health center patients","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116378","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"116378"}}